Climb Bio Inc share price logo

Climb Bio Inc Share Price

NASDAQ: CLYM

Small Cap

$1.93

-0.02

(-1.28%)

as on

Climb Bio Inc Stock Performance

as on October 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.82
    $1.99
    downward going graph

    5.70%

    Downside

    3.11%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.05
    $5.1
    downward going graph

    45.60%

    Downside

    164.25%

    Upside

    downward going graph

Climb Bio Inc share price movements today

Previous Close
$1.95
Open
$1.97
Volume
928.1K
Day's Low - High
$1.82 - $1.99
52 Week Low - High
$1.05 - $5.1

Climb Bio Inc Historical Returns

1 Month Return
-13.84 %
3 Month Return
+ 27.81 %
1 Year Return
-61.55 %
3 Year Return
0 %
5 Year Return
0 %

Climb Bio Inc Stock Fundamentals & Key Indicators

Check Climb Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$132.1M

EPS (TTM)

-0.75

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

323100.00%

Climb Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Climb Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$132.1MNANA0.00%
BUY$63.1B231.27%-505.15-12.96%
NA$36.7BNANA-3.89%
BUY$104.8B91.13%29.0431.86%
BUY$60.3B-3.62%14.3531.37%

Stock Returns calculator for Climb Bio Inc Stock including INR - Dollar returns

The Climb Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Climb Bio Inc investment value today

Current value as on today

₹43,241

Returns

₹56,759

(-56.76%)

Returns from Climb Bio Inc Stock

₹61,554 (-61.55%)

Dollar Returns*

₹4,794 (+4.79%)

Climb Bio Inc Stock’s Investor Sentiment and Interest

Search interest for Climb Bio Inc Stock has increased by 30% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:30% versus previous 30 day period

Climb Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
0
Operating Income
-6
-5
-5
-3
-56
-11
-10
-23
-10
EBITDA
-6
-5
-5
-3
-56
-11
-10
-23
-8
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-5
-3
-3
-1
-54
-8
-8
-20
-8
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-5
-3
-3
-1
-54
-8
-8
-20
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Climb Bio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Income
-20
-35
-45
-40
-82
EBITDA
-11
-35
-45
-40
-30
Interest Expense
-
-
-
-
-
Depreciation
-
-
-
-
-
Income Before Tax
-20
-47
-45
-35
-73
Income Tax Expense
-
-
-
-
-
Net Income
-20
-47
-45
-35
-73
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Climb Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-5
-3
-3
-1
-54
-8
-8
-20
-8
Operating Cash Flow
-7
3
0
-1
0
-7
-5
-15
-11
Investing Cash Flow
-1
28
36
13
-9
-71
-53
-42
4
Financing Cash Flow
0
0
0
0
128
2
0
-
-
Change in Cash
-9
32
35
11
118
-76
-58
-58
-6

Climb Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-20
-47
-45
-35
-73
Operating Cash Flow
-14
-36
-37
-20
-15
Investing Cash Flow
8
-114
34
68
-121
Financing Cash Flow
4
177
-
0
130
Change in Cash
0
26
-3
49
-5

Insights on Climb Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 124.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 148.2% return, outperforming this stock by 194.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, CLYM stock has moved down by -61.6%

About Climb Bio Inc

Climb Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics for patients with immune-mediated diseases. The Company’s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody designed to deplete CD19-positive B cells, including antibody-secreting cells, in order to directly reduce pathogenic autoantibodies. The reduction of autoantibodies has the potential to be disease-modifying in autoantibody-driven diseases, such as systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. The budoprutug is in a Phase Ib/IIa clinical trial. The Company is also developing CLYM116, an anti-APRIL antibody, in investigational new drug applications (IND)-enabling studies for IgA nephropathy (IgAN).
OrganisationClimb Bio Inc
Headquarters20 William Street, Wellesley Hills, MA, United States, 02481
CEODr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
E-voting on sharesClick here to vote

Key Management of Climb Bio Inc

Name

Title

Ms. Kate Hecht M.B.A.

Senior Vice President of Program Management

Dr. Perrin Wilson B.S., Ph.D.

Chief Business Officer

Dr. Edgar D. Charles M.D., M.Sc.

Chief Medical Officer

Ms. Cindy J. Driscoll M.B.A.

Senior Vice President of Finance

Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc

CEO, President & Director

Dr. Susan Altschuller M.B.A., Ph.D.

Chief Financial Officer

Ms. Chandra Adams J.D.

VP & General Counsel

Ms. Janaki M. Subramanyam M.Sc.

VP & Head of Regulatory Affairs

FAQs

What is Climb Bio Inc share price today?

Climb Bio Inc share price today is $1.93 as on at the close of the market. Climb Bio Inc share today touched a day high of $1.99 and a low of $1.82.

What is the 52 week high and 52 week low for Climb Bio Inc share?

Climb Bio Inc share touched a 52 week high of $5.1 on and a 52 week low of $1.05 on . Climb Bio Inc stock price today i.e. is closed at $1.93,which is 62.16% down from its 52 week high and 83.81% up from its 52 week low.

What is Climb Bio Inc's market capitalisation today?

Climb Bio Inc market capitalisation is $0.00T as on .

How to invest in Climb Bio Inc Stock (CLYM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Climb Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Climb Bio Inc Shares that will get you 0.7772 shares as per Climb Bio Inc share price of $1.93 per share as on October 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Climb Bio Inc Stock (CLYM) from India?

Indian investors can start investing in Climb Bio Inc (CLYM) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Climb Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Climb Bio Inc share’s latest price of $1.93 as on October 18, 2025 at 1:29 am IST, you will get 5.1813 shares of Climb Bio Inc. Learn more about fractional shares .